Achillion Pharma Appoints Steven Zelenkofske Chief Medical Officer

Xconomy New York — 

Steven Zelenkofske has joined Achillion Pharmaceuticals (NASDAQ: ACHN) as executive vice president and chief medical officer of the New Haven, CT, drug developer. Zelenkofske most recently worked at uniQure (NASDAQ: QURE), where he was chief medical officer. He has also held leadership positions at Regado Biosciences, AstraZeneca (NYSE: AZN), Sanofi-Aventis, Boston Scientific (NYSE: BSX), and Novartis (NYSE: NVS). Achillion develops drugs to treat rare immune disorders.